Literature DB >> 18509748

Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.

Chuangui Chen1, Jinjin Sun, Geng Liu, Jianqiu Chen.   

Abstract

To study the effect of recombinant adeno-associated virus (rAAV) vector bearing small inference RNA (siRNA) targeting hypoxia inducible factor 1alpha (HIF-1alpha) combined L: -ascorbate on pancreatic tumors in athymic mice primarily. A cassette encoding siRNA targeting HIF-1alpha mediated by rAAV was constructed, giving rAAV-siHIF. In vitro, rAAV-hrGFP, rAAV-siHIF and L: -ascorbate which were used alone or in combination were delivered to exponentially growing MiaPaCa2 cells. Then, we examined the expression of HIF-1alpha mRNA and protein, the secretion of VEGF in MiaPaCa2 cells under hypoxic condition with Real-time PCR, Western Blot, ELISA, respectively. In vivo, MiaPaCa2 cells were inoculated subcutaneously on the back of nude mice. Nude mice with xenograft tumor were randomly divided into equal groups and were injected with rAAV-hrGFP or rAAV-siHIF or were fed with L: -ascorbate. Then, we measured the size of tumor every 3 days and drew a tumor growth curve. After 30 days, all mice were sacrificed and the tumors were dissected. At last, we examined the expression of HIF-1alpha, VEGF and CD34 by immunohistochemistry and counted micro-vessel density (MVD). In vitro, we found that rAAV-siHIF could inhibit the expression of HIF-1alpha mRNA and protein in MiaPaCa2 human pancreatic cancer cells but L: -ascorbate could only restrain the expression of HIF-1alpha protein. Moreover, rAAV-siHIF and L: -ascorbate could all inhibit the secretion of vascular VEGF. In vivo, we found that rAAV-siHIF could inhibit the growth of nude mice xenograft tumor and the expression of HIF-1alpha and VEGF and MVD while L: -ascorbate can only inhibit the growth of xenograft tumor in the early and middle stage. These results suggest that rAAV-siHIF and L: -ascorbate can inhibit the growth of nude mice xenograft tumor and HIF-1alpha could be a target of pancreatic cancer genetic and pharmacological therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509748     DOI: 10.1007/s12253-008-9063-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

Review 1.  RNA interference: listening to the sound of silence.

Authors:  P D Zamore
Journal:  Nat Struct Biol       Date:  2001-09

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  Use of adeno-associated viral vector for delivery of small interfering RNA.

Authors:  Raghuvir S Tomar; Hittu Matta; Preet M Chaudhary
Journal:  Oncogene       Date:  2003-08-28       Impact factor: 9.867

Review 4.  Therapeutic potentials of angiostatin in the treatment of cancer.

Authors:  Y Cao
Journal:  Haematologica       Date:  1999-07       Impact factor: 9.941

5.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

Review 7.  HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.

Authors:  Nathalie M Mazure; M Christiane Brahimi-Horn; Mélanie A Berta; Emmanuel Benizri; Rebecca L Bilton; Frédéric Dayan; Amandine Ginouvès; Edurne Berra; Jacques Pouysségur
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

8.  Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.

Authors:  Peter Büchler; Howard A Reber; Manuela Büchler; Shailesh Shrinkante; Markus W Büchler; Helmut Friess; Gregg L Semenza; Oscar J Hines
Journal:  Pancreas       Date:  2003-01       Impact factor: 3.327

9.  Expression of snail in pancreatic cancer promotes metastasis and chemoresistance.

Authors:  Tao Yin; Chunyou Wang; Tao Liu; Gang Zhao; Yunhong Zha; Ming Yang
Journal:  J Surg Res       Date:  2007-06-20       Impact factor: 2.192

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  6 in total

1.  DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma.

Authors:  Santanu Bhattacharya; Xun Gong; Enfeng Wang; Shamit K Dutta; Joseph R Caplette; Manki Son; Freddy T Nguyen; Michael S Strano; Debabrata Mukhopadhyay
Journal:  Cancer Res       Date:  2019-07-10       Impact factor: 12.701

2.  L-ascorbic acid: A true substrate for HIF prolyl hydroxylase?

Authors:  Andrey I Osipyants; Andrey A Poloznikov; Natalya A Smirnova; Dmitry M Hushpulian; Anna Yu Khristichenko; Tatiana A Chubar; Arpenik A Zakhariants; Manuj Ahuja; Irina N Gaisina; Bobby Thomas; Abe M Brown; Irina G Gazaryan; Vladimir I Tishkov
Journal:  Biochimie       Date:  2017-12-28       Impact factor: 4.079

3.  The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Chen Chuangui; Tang Peng; Yu Zhentao
Journal:  Pathol Oncol Res       Date:  2012-04-29       Impact factor: 3.201

Review 4.  Research progress on siRNA delivery with nonviral carriers.

Authors:  Yan Gao; Xin-Ling Liu; Xiao-Rong Li
Journal:  Int J Nanomedicine       Date:  2011-05-11

5.  High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma.

Authors:  Min-Seok Seo; Ja-Kyung Kim; Jae-Yong Shim
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

6.  Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer.

Authors:  Caroline Kuiper; Gabi U Dachs; Delwyn Munn; Margaret J Currie; Bridget A Robinson; John F Pearson; Margreet C M Vissers
Journal:  Front Oncol       Date:  2014-02-04       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.